Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-18-001059
Filing Date
2018-05-15
Accepted
2018-05-14 19:57:57
Documents
9
Period of Report
2018-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 12570
2 Q2 FINANCIAL STATEMENTS ex991.htm EX-99.1 344660
3 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 310749
4 CEO CERTIFICATION ex993.htm EX-99.3 6825
5 CFO CERTIFICATION ex994.htm EX-99.4 6801
6 NEWS RELEASE DATED MAY 14, 2018 ex995.htm EX-99.5 42418
7 GRAPHIC image_001.jpg GRAPHIC 69123
8 GRAPHIC image_002.jpg GRAPHIC 61533
9 GRAPHIC image_003.jpg GRAPHIC 2004
  Complete submission text file 0001279569-18-001059.txt   907943
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 18832638
SIC: 2834 Pharmaceutical Preparations